Healthcare provider profile · identity verified

Mark Kielbiowski, MD

Family Practice · GREENSBURG, PA · NPI 1982826285

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	741	196
Levothyroxine Sodium	Levothyroxine Sodium	624	128
Amlodipine Besylate	Amlodipine Besylate	507	123
Lisinopril	Lisinopril	486	127
Omeprazole	Omeprazole	383	77
Metformin Hcl	Metformin Hcl	374	89
Rosuvastatin Calcium	Rosuvastatin Calcium	321	109
Jardiance	Empagliflozin	280	47
Ozempic	Semaglutide	265	54
Gabapentin	Gabapentin	258	43
Pantoprazole Sodium	Pantoprazole Sodium	235	60
Alendronate Sodium	Alendronate Sodium	198	40
Losartan Potassium	Losartan Potassium	192	51
Metoprolol Tartrate	Metoprolol Tartrate	172	44
Hydrochlorothiazide	Hydrochlorothiazide	169	42
Albuterol Sulfate Hfa	Albuterol Sulfate	164	45
Simvastatin	Simvastatin	157	41
Potassium Chloride	Potassium Chloride	152	37
Sertraline Hcl	Sertraline Hcl	152	38
Montelukast Sodium	Montelukast Sodium	134	22
Trazodone Hcl	Trazodone Hcl	131	28
Lorazepam	Lorazepam	130	31
Duloxetine Hcl	Duloxetine Hcl	125	21
Furosemide	Furosemide	124	37
Metoprolol Succinate	Metoprolol Succinate	118	26
Eliquis	Apixaban	112	23
Tamsulosin Hcl	Tamsulosin Hcl	106	31
Tizanidine Hcl	Tizanidine Hcl	103	22
Zolpidem Tartrate	Zolpidem Tartrate	101	17
Fluoxetine Hcl	Fluoxetine Hcl	98	25
Famotidine	Famotidine	91	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	16
Pravastatin Sodium	Pravastatin Sodium	90	25
Azithromycin	Azithromycin	85	75
Alprazolam	Alprazolam	84	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	20
Fluticasone Propionate	Fluticasone Propionate	83	28
Allopurinol	Allopurinol	78	21
Escitalopram Oxalate	Escitalopram Oxalate	77	20
Cephalexin	Cephalexin	76	53
Xarelto	Rivaroxaban	69	14
Metformin Hcl Er	Metformin Hcl	68	21
Prednisone	Prednisone	68	45
Bupropion Hcl Sr	Bupropion Hcl	67	15
Chlorhexidine Gluconate	Chlorhexidine Gluconate	56	suppressed
Atenolol	Atenolol	55	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	55	12
Clopidogrel	Clopidogrel Bisulfate	52	16
Carvedilol	Carvedilol	51	suppressed
Clonazepam	Clonazepam	51	suppressed
Synthroid	Levothyroxine Sodium	50	12
Trulicity	Dulaglutide	50	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	14
Ondansetron Odt	Ondansetron	48	19
Ezetimibe	Ezetimibe	45	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	42	suppressed
Tramadol Hcl	Tramadol Hcl	41	11
Pregabalin	Pregabalin	40	suppressed
Meclizine Hcl	Meclizine Hcl	38	11
Irbesartan	Irbesartan	37	suppressed
Mounjaro	Tirzepatide	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	29
Finasteride	Finasteride	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Naproxen	Naproxen	35	11
Ondansetron Hcl	Ondansetron Hcl	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	suppressed
Clotrimazole	Clotrimazole	33	15
Doxycycline Monohydrate	Doxycycline Monohydrate	33	31
Methocarbamol	Methocarbamol	32	suppressed
Sucralfate	Sucralfate	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	24
Ventolin Hfa	Albuterol Sulfate	31	13
Advair Hfa	Fluticasone Propion/Salmeterol	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Meloxicam	Meloxicam	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	11
Spironolactone	Spironolactone	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Lactulose	Lactulose	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Baclofen	Baclofen	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Primidone	Primidone	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	12
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Temazepam	Temazepam	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Dantrolene Sodium	Dantrolene Sodium	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Topiramate	Topiramate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Carbamazepine	Carbamazepine	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error